Roivant Sciences

Roivant Sciences is a biopharmaceutical company dedicated to improving patients' lives by rapidly developing and commercializing medicines that address significant unmet medical needs. They employ a unique model where they build agile, focused subsidiaries called Vants, each specializing in a specific therapeutic area. This approach allows Roivant to efficiently allocate resources and capital, accelerate development timelines, and bring innovative treatments to market more quickly.

The company boasts a diverse portfolio of Vants spanning multiple therapeutic areas, including immunology, oncology, hematology, and dermatology. Roivant's commitment to innovation is evident in their track record, including 10 positive Phase 3 trials since 2019 and the successful launch of VTAMA®, (tapinarof) cream, 1%, for the treatment of plaque psoriasis in adults. This innovative approach, coupled with their robust pipeline of investigational drugs, positions Roivant as a leading force in the pharmaceutical industry.

Roivant offers employees a range of work flexibility options, including in-office, hybrid, and remote work opportunities. The company supports and enables employees' preferred work environments, providing in-office perks, remote work stipends, and commuter benefits. They encourage employees to work across multiple therapeutic areas and modalities, fostering a culture of continuous learning and professional growth. This cross-disciplinary approach benefits research outcomes and helps employees expand their skills and stay mobile within the organization.

Roivant offers a comprehensive benefits package designed to support employees both at work and at home. These benefits include exceptional medical, dental, and vision coverage, a 401(k) plan with a company match, unlimited paid time off, generous parental and family leave, work-from-home and commuter benefits, and access to employee resource groups.

Roivant Sciences is a biopharmaceutical company focused on improving patient lives by accelerating the development and commercialization of transformative medicines and technologies. They achieve this by creating agile, focused subsidiaries called "Vants," which operate independently with their own dedicated teams and resources. This innovative model allows Roivant to efficiently allocate capital and prioritize high-growth areas, while fostering a culture of innovation and collaboration within their diverse and inclusive workforce.

Roivant cultivates a culture that values innovation, diversity, and collaboration. They believe in empowering employees to architect their own careers through non-linear trajectories, fostering a growth-oriented environment. Their commitment to diversity is reflected in their efforts to attract and retain top talent from various backgrounds and industries, promoting inclusion and belonging through employee resource groups. Roivant encourages open communication and feedback, creating a transparent and connected workplace.

Roivant prioritizes diversity, equity, and inclusion across all levels of the organization. They actively seek out and hire motivated individuals from diverse backgrounds, identities, experiences, and skillsets. The company fosters an inclusive culture where all employees feel valued, respected, and empowered to reach their full potential. Their initiatives include unconscious bias training, employee resource groups (ERGs) like Women@Roivant, BIPOC, and ROI-GBIV, and community engagement initiatives focused on equitable access to essential services. They also have a robust early career development program, offering opportunities for recent college graduates and Pharm.D. candidates. Roivant aims to create a workplace where everyone has the opportunity to thrive and contribute to their mission of improving human health.